Detection of Breast Cancer in Nipple Aspirate Fluid by CpG Island Hypermethylation

Clinical Cancer Research

Volumn 10, Issue 1 I, 2004, Pages 28-32

  Krassenstein, Rachel ^a   Sauter, Edward ^b   Dulaimi, Essel ^a   Battagli, Cristina ^a   Ehya, Hormoz ^a   Klein Szanto, Andres ^a   Cairns, Paul ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; DEATH ASSOCIATED PROTEIN KINASE; DNA; GLUTATHIONE TRANSFERASE; PROTEIN MLH1; PROTEIN P14; PROTEIN P16; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RETINOIC ACID RECEPTOR BETA; TUMOR MARKER;

ADULT; AGED; ARTICLE; ASPIRATION; BREAST CANCER; BREAST EPITHELIUM; CANCER GENETICS; CANCER SCREENING; CANCER STAGING; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DIAGNOSTIC ACCURACY; DNA DETERMINATION; DNA METHYLATION; DRUG TARGETING; EARLY DIAGNOSIS; EPITHELIUM CELL; FEMALE; GENE IDENTIFICATION; GENE INACTIVATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SENSITIVITY AND SPECIFICITY; TECHNIQUE; TUMOR SUPPRESSOR GENE;

ADULT; AGED; APOPTOSIS REGULATORY PROTEINS; BIOPSY, NEEDLE; BODY FLUIDS; BREAST NEOPLASMS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CASE-CONTROL STUDIES; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA, NEOPLASM; EPITHELIAL CELLS; FEASIBILITY STUDIES; FEMALE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; MIDDLE AGED; NEOPLASM PROTEINS; NIPPLES; PROMOTER REGIONS (GENETICS); RECEPTORS, RETINOIC ACID; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEINS;

EID: 1642576173     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-0410-3     Document Type: Article

References (31)

1. Couch, F. J., and Weber, B. L. Breast Cancer. In: Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., Childs, B., Kinzler, K. W., and Vogelstein, B. The Metabolic and Molecular Basis of Human Disease, Ed. 3, Vol. 1, Chp. 47, pp. 999-1031. McGraw-Hill, Inc., 2001.
2. Jemal, A., Thomas, A., Murray, T., and Thun, M. Cancer statistics, 2002. CA - Cancer J. Clin., 52: 23-47, 2002.
3. Sauter, E. R., Daly, M., Klein-Szanto, A., Engstrom, P. F., Sorling, A., Malik, J., and Ehya H Nipple aspirate fluid: a promising noninvasive method to identify cellular markers of breast cancer risk, Br. J. Cancer, 76: 494-501, 1997.
4. Sidransky, D. Nucleic acid-based methods for the detection of cancer. Science (Wash. DC), 278: 1054-1058, 1997.
5. Baylin, S. B., Herman, J. G., Graff, J. R., Vertino, P. M., and Issa, J-P. J. Alterations in DNA methylation: a fundamental aspect of neoplasia, Adv. Cancer Res., 72: 141-196, 1998.
6. Jones, P. A., and Laird, P. W. Cancer epigenetics comes of age. Nat. Genet., 21: 163-167, 1999.
7. Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996.
8. Wong, I. H. N., Lo, Y. M. D., Zhang, J., Liew, C-T., Ng, M. H. L., Wong, N., Lai, P. B. S., Lau, W. Y., Hjelm, M., and Johnson, P. J. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res., 59: 71-73, 1999.
9. Esteller, M., Sanchez-Cespedes, M., Rosell, R., Sidransky, D., Baylin, S. B., and Herman, J. G. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res., 59: 67-70, 1999.
10. Sanchez-Cespedes, M., Esteller, M., Wu, L., Nawroz-Danish, H., Yoo, G. H., Koch, W. M., Jen, J., Herman, J. G., and Sidransky, D. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res., 60: 892-895, 2000.
11. INK4a is an early event in lung cancer and a potential biomarker for early diagnosis. Proc. Natl. Acad. Sci. USA, 95: 11891-11896, 1998.
12. Ahrendt, S. A., Chow, J. T., Xu, L-H., Yang, S. C., Eisenberger, C. F., Esteller, M., Herman, J. G., Wu, L., Decker, P. A., Jen, J., and Sidransky, D. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J. Natl. Cancer Inst. (Bethesda), 91: 332-339, 1999.
13. Cairns, P., Esteller, M., Herman, J. G., Schoenberg, M., Jeronimo, C., Sanchez-Cespedes, M., Chow, N-H., Grasso, M., Wu, L., Westra, W. B., and Sidransky, D. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin. Cancer Res., 7: 2727-2730, 2001.
14. Esteller, M., Com, P. G., Urena, J. M., Gabrielson, E., Baylin, S. B., and Herman, J. G. Inactivation of glutathione S-transferase PI gene by promoter hypermethylation in human neoplasia. Cancer Res., 58: 4515-4518, 1998.
15. Cote, S., Sinnett, D., and Momparler, R. L. Demethylation by 5-aza-2′-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor β gene in human colon carcinoma cells. Anticancer Drugs, 9: 743-750, 1998.
16. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J-P. J., Davidson, N. E., Sidransky, D., and Baylin, S. B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55: 4525-4530, 1995.
17. Esteller, M., Com, P. G., Baylin, S. B., and Herman, J. G. A gene hypermethylation profile of human cancer. Cancer Res., 61: 3225-3229, 2001.
18. Dammann, R., Li, C., Yoon, J-H., Chin, P. L., Bates, S., and Pfeifer, G. P. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat. Genet., 25: 315-319, 2000.
19. Katzenellenbogen, R. A., Baylin, S. B., and Herman, J. G. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood, 93: 4347-4353, 1999.
20. Esteller, M., Tortola, S., Toyota, M., Capella, G., Peinado, M. A., Baylin, S. B., and Herman, J. G. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res., 60: 129-133, 2000.
21. Widschwendter, M., Berger, J., Hermann, M., Müller, H. M., Amberger, A., Zeschnigk, M., Widschwendter, A., Abendstein, B., Zeimet, A. G., Daxenbichler, G., and Marth, C. Methylation and silencing of the retinoic acid receptor-β2 gene in breast cancer. J. Natl. Cancer Inst. (Bethesda), 92: 826-832, 2000.
22. Dammann, R., Yang, G., and Pfeifer, G. P. Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res., 61: 3105-3109, 2001.
23. Corn, P. G., Smith, B. D., Ruckdeschel, E. S., Douglas, D., Baylin, S. B., and Herman, J. G. E-Cadherin expression is silenced by 5' CpG island methylation in acute leukemia. Clin. Cancer Res., 6: 4243-4248, 2000.
24. Palmisano, W. A., Divine, K. K., Saccomanno, G., Gilliland, F. D., Baylin, S. B., Herman, J. G., and Belinsky, S. A. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res., 60: 5954-5958, 2000.
25. Lee, W-H., Morton, R. A., Epstein, J. I., Brooks, J. D., Campbell, P. A., Bova, G. S., Hsieh, W-S., Isaacs, W. B., and Nelson, W. G. Cytidine methylation of regulatory sequences near the π-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl. Acad. Sci. USA, 91: 11733-11737, 1994.
26. Tchou, J. C., Lin, X., Freije, D., Isaacs, W. B., Brooks, J. D., Rashid, A., De Marzo, A. M., Kanai, Y., Hirohashi, S., and Nelson, W. G. GSTPI CpG island DNA hypermethylation in hepatocellular carcinomas. Int. J. Oncol., 16: 663-676, 2000.
27. Costello, J. F., Frühwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomäki, P., Lang, J. C., Schuller, D. E., Yu, L., Bloomfield, C. D., Caligiuri, M. A., Yates, A., Nishikawa, R., Huang, H-J. S., Petrelli, N. J., Zhang, X., O'Dorisio, M. S., Held, W. A., Cavenee, W. K., and Plass, C. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet., 25: 132-138, 2000.
28. Yan, P. S., Chen, C. M., Shi, H., Rahmatpanah, F., Wei, S. H., Caldwell, C. W., and Huang, T. H. Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays. Cancer Res., 61: 8375-8380, 2001.
29. Esteller, M., Silva, J. M., Dominguez, G., Bonilla, F., Matias-Guiu, X., Lerma, E., Bussaglia, E., Prat, J., Harkes, I. C., Repasky, E. A., Gabrielson, E., Schutte, M., Baylin, S. B., and Herman, J. G. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl. Cancer Inst. (Bethesda), 92: 564-569, 2000.
30. Evron, E., Dooley, W. C., Umbricht, C. B., Rosenthal, D., Sacchi, N., Gabrielson, E., Soito, A. B., Hung, D. T., Ljung, B-M., Davidson, N. E., and Sukumar, S. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR. Lancet, 357: 1335-1336, 2001.
31. Silva, J. M., Dominguez, G., Villanueva, M. J., Gonzalez, R., Garcia, J. M., Corbacho, C., Provencio, M., Espana, P., and Bonilla, F. Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients. Br. J. Cancer 80: 1262-1264, 1999.